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SUMMARY
Abnormal gut-associated lymphoid tissue (GALT) in humans is associated with infectious and
autoimmune diseases, which cause dysfunction of the gastrointestinal (GI) tract immune system.
To aid in investigating GALT pathologies in vivo, we bioengineered a human-mouse chimeric
model characterized by the development of human GALT structures originating in mouse
cryptopatches. This novel observation represents a fundamental breakthrough in our mechanistic
understanding of the role of cryptopatches in human GALT genesis and emphasizesthe
evolutionary conservation of this developmental process between humans and mice.
Immunoglobulin class switching to IgA occurs in these GALT structures leading to numerous
human IgA-producing plasma cells throughout the intestinal lamina propria. CD4+ T cell depletion
within GALT structures results from HIV infection, as in humans. This human-mouse chimeric
model represents the most comprehensive experimental platform currently available for the study
and the pre-clinical efficacy testing of therapeutics designed to repair disease-damaged GALT.
INTRODUCTION
The mammalian gastrointestinal (GI) tract contains a well-organized immune system
consisting of the gut-associated lymphoid tissues (GALT) and the diffuse intestinal lamina
propria. GALT includes Peyer’s patches (PPs) and isolated lymphoid follicles (ILFs) where
antigen-primed T and B cells are activated. These cells then migrate into the lamina propria
where protective immune responses against invasive microorganisms and pathogenic toxins
occur (McGhee et al., 2007; Pabst, 2012). GALT and lamina propria are distinct tissues that
together form the GI tract immune system which is critically important in the maintenance
of health by providing a protective barrier between the host and a GI microbial ecosystem
(Hooper and Macpherson, 2010; Pabst, 2012). A key component of this activity is IgA
production, as this molecule inhibits bacterial penetration into intestinal tissue and aids in
the maintenance of symbiotic relationships formed between beneficial commensal
microbiota and the host (Hooper and Macpherson, 2010; McGhee et al., 2007; Pabst, 2012).
Since a functional GALT is an essential component of the GI tract immune system, immune
dysfunctions associated with abnormalities of the GALT lead to major health concerns
(Brenchley and Douek, 2008; Khor et al., 2011). For example, human immunodeficiency
virus (HIV) infection causes massive CD4+ T cell depletion in the GI tract immune system
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(Brenchley and Douek, 2008; Mehandru et al., 2004). The resulting dysfunction has been
linked to abnormal microbial translocation and immune activation, resulting in increased
morbidity and mortality in HIV-infected individuals (Brenchley et al., 2006). Inflammatory
bowel diseases (IBDs) (i.e., ulcerative colitis and Crohn’s disease) also have major physical
manifestations that cause long-term patient distress (Khor et al., 2011) due primarily to
overactive GALT (e.g., anomalous hyperplasia of ILFs which leads to excess production of
the pro-inflammatory tumor necrosis factor [TNF] α) (Yeung et al., 2000). Successfully
achieving our goal of generating an in vivo xenograft model characterized by the presence
of human GALT would greatly benefit research focused on gaining a comprehensive
understanding of the mechanisms that lead to these GALT pathologies. Furthermore, the
availability of such a model would fill a critical need for an in vivo experimental platform
for preclinical efficacy testing of therapeutic interventions to treat infectious and
autoimmune disease-induced GALT pathologies.
In mice, the molecular and cellular mechanisms by which GALT develops have been
extensively characterized. ILF formation is environmentally induced postnatally by
commensal microbiota and requires cryptopatches containing lymphoid tissue inducer (LTi)
cells – a distinct population of Group 3 innate lymphoid cells (Eberl, 2005; Lorenz et al.,
2003; Spits et al., 2013; van de Pavert and Mebius, 2010). During ILF genesis, intestinal
epithelial cells produce IL-7 that signals via the IL-7 receptor on LTi cells to induce the
expression of lymphotoxin α1β2 (LT-α1β2) (Eberl, 2005; van de Pavert and Mebius, 2010).
LT-α1β2 binds to the lymphotoxin β receptor (LTβR) on resident lymphoid tissue organizer
(LTo) cells to up-regulate the expression of chemokines (e.g., CXCL13, CCL19 and
CCL21) and adhesion molecules (e.g., VCAM1 and ICAM1) for the recruitment and
retention of lymphocytes into the cryptopatches (Eberl, 2005; van de Pavert and Mebius,
2010). This cell-to-cell signaling cascade reveals that IL-7R signaling is absolutely essential
for GALT genesis such that normal GALT development fails to occur in mice with impaired
IL-7R signaling including IL-7Rαnull mice and mice lacking the common gamma chain
(IL-2Rγnull mice) (Hamada et al., 2002; Ivanov et al., 2006).
In contrast to our significant knowledge of GALT genesis in mice, this process is poorly
understood in humans. Cryptopatches have been considered absent in humans (Moghaddami
et al., 1998; Pabst et al., 2005); however, a recent histological study revealed the presence of
cryptopatch-like structures in human gut (Lugering et al., 2010). This key observation led us
to test whether mouse cryptopatches could serve as anlagen for human GALT genesis using
a chimeric model. For these studies, we used bone marrow-liver-thymus (BLT) humanized
mice (Denton et al., 2012; Lan et al., 2006; Melkus et al., 2006) constructed in two closely
related, lymphocyte-lacking, immunodeficient mouse strains that differ in their ability to
develop cryptopatches (i.e., NOD/SCID (N/S] and NOD/SCID IL-2Rγnull [NSG]).
Specifically, N/S mice have cryptopatches while NSG mice lack these structures because of
the absence of a functional IL-2Rγ chain. We hypothesized that the cryptopatches of N/S
mice could serve as anlagen for the development of human GALT in BLT humanized N/S
(N/S-BLT) mice. Accordingly, we show that human GALT structures develop in the host
cryptopatches of N/S-BLT mice. Moreover, HIV infection of N/S-BLT mice results in
specific human CD4+ T cell depletion in the GALT structures. These observations highlight
the potential of this model for the study of human GALT development in vivo and for
performing pre-clinical evaluation of therapeutics interventions designed to treat important
GALT-associated clinical conditions.
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Cryptopatches containing LTi cells, the anlagen for GALT genesis, are present in N/S but
not NSG mice
To establish a baseline for GALT genesis in N/S and NSG mice, we examined the GI tract
of non-humanized mice. Immune competent BALB/c mice were used as a reference and
positive control for the identification of cryptopatches and other relevant GALT structures in
mice. We found that cryptopatches develop between the intestinal crypts in N/S, but not
NSG, mice (Figure 1A). Immunofluorescence analyses (IFA) revealed that N/S and BALB/c
mouse cryptopatches contain mouse IL-7Rα (mIL-7Rα)+ cells and mCD11c+ dendritic cells
(Figure 1B). In immunocompetent mice, infiltrating lymphoid cells typically expand
cryptopatches into ILFs (Eberl, 2005; Eberl and Littman, 2004; van de Pavert and Mebius,
2010). Interestingly, although N/S and NSG mice lack mouse T and B cells (Shultz et al.,
2005) (Figures 1B-D), the cryptopatches in N/S mice become enlarged with a follicle-
associated epithelium that is morphologically similar to BALB/c mouse GALT (e.g., ILFs
and PPs) (Figure 1A). These enlarged structures in N/S mice contain mIL-7Rα+ cells
and mCD11c+ dendritic cells and they lack the lymphoid follicles composed of mCD3+ T
and mB220+ B cells that are found in BALB/c mouse GALT (Figure 1B). We used
polychromatic flow cytometry to analyze cells isolated from small intestines (SI) of these
mice. Within the mouse lineage marker (mCD3, mB220, mCD11b, mGr-1 and mTER-119)
negative population, we identified mIL-7Rα+mc-kit+ innate lymphoid cells in N/S and
BALB/c, but not NSG, mice (Figures 1E and 1F). Further examination of the mIL-7Rα+mc-
kit+ innate lymphoid cells revealed that a small fraction of this population also
expressed mCD4 which defined these cells as LTi cells (Spits et al., 2013) (Figure S1A).
However, the majority of the mIL-7Rα+mc-kit+ population also expressed mNKp46+ which
defined these cells as a separate subset of Group 3 innate lymphoid cells known as natural
cytotoxicity triggering receptor (NCR)+ cells (Figure S1A) (Spits et al., 2013). These cells
were primarily located in the lamina propria of N/S mice and were not present in NSG mice
(Figure S1B). Together, these results demonstrate that N/S mice have cryptopatches
containing LTi cells that could serve as potential anlagen for the development of human
GALT in their GI tract.
Reconstitution of N/S-BLT and NSG-BLT mice with human hematopoietic cells
For our study, we utilized 26 BLT mice exhibiting comparable systemic humanization (N/S-
BLT, n=13; NSG-BLT, n=13). Specifically, the average percentage of hCD45+ cells in the
peripheral blood of N/S-BLT mice was 52 % (+/− 20 % SD) of which 71 % (+/− 21 % SD)
were hCD3+ T cells and 15 % (+/− 19 % SD) were hCD19+ B cells. Similarly, the average
percentage of hCD45+ cells in the peripheral blood of NSG-BLT mice was 71 % (+/− 13 %
SD) of which 80 % (+/− 18 % SD) were hCD3+ T cells and 9 % (+/− 14 % SD)
were hCD19+ B cells. Systemic reconstitution with human hematopoietic cells in peripheral
tissues (e.g., spleen, liver, lung) was comparable between N/S-BLT and the NSG-BLT mice
(not shown) and (Denton et al., 2012). Therefore, these 2 types of BLT mice, one with and
one without cryptopatches, were specifically chosen to test our hypothesis that
cryptopatches can serve as suitable anlagen or foundation for human GALT development.
Development of human GALT structures in N/S-BLT mice
When we examined the GI tract immune system in N/S-BLT and NSG-BLT mice, we noted
that expanded immune aggregates were present in the SI of 13 of 13 N/S-BLT mice while
none were present in the SI of 13 NSG-BLT mice (Figure 2A) (p<0.0001; Fisher’s exact
test). This highly reproducible observation was consistent with our hypothesis.
Polychromatic flow cytometry analysis with cells isolated from the SI of N/S-BLT
humanized mice revealed that human Group 3 innate lymphoid cells
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[hCD3neghCD4neghCD45+hIL-7Rα+hc-kit+ (Spits et al., 2013)] are present, albeit in very
small numbers (Figure S1C). Immunofluorescence analysis of the immune aggregates
present in the SI revealed that hCD45+ cells accumulated into cryptopatches together
with mCD45+ cells (Figure 2B). As they expanded, these lymphoid aggregates harbored
greater numbers of hCD45+ cells than mCD45+ cells (Figure 2B). Moreover, the human
hematopoietic lineages present in expanded lymphoid aggregates included hCD3+ T
cells, hCD19+ B cells, hCD11c+ dendritic cells and hCD68+ macrophages (Figure 3A),
defining these as human GALT structures (Jung et al., 2010). The specificity of all the
antibodies to human antigens used in our analyses was carefully confirmed by parallel
staining of tissues obtained from non-humanized N/S and NSG mouse intestines (not
shown). In summary, the presence or absence of cryptopatches in the two different strains
used to generate BLT mice corresponded directly to the presence or the lack of human
GALT structures.
Comprehensive characterization of the GI tract human immune reconstitution in BLT mice
The GI tract immune system consists of multiple compartments: GALT, diffuse lamina
propria, and an epithelial cell monolayer harboring intraepithelial lymphocytes (McGhee et
al., 2007; Pabst, 2012). GALT is where mature naïve B cells differentiate into class-
switched IgA+ cells that localize to the intestinal lamina propria (McGhee et al., 2007; Pabst,
2012). Intraepithelial lymphocytes in N/S-BLT mice include human CD8+ T cells, CD4+ T
cells, natural killer cells and myeloid dendritic cells; but not γδ T cells (Sun et al., 2007).
The difference observed in the ability of human GALT to develop in N/S-BLT versus NSG-
BLT mice led us to hypothesize that this difference would influence the human immune cell
lineages present in the mouse intestinal lamina propria. Therefore, we performed flow
cytometry analyses on cells isolated from SI. We found equivalent numbers of hCD3+ T
cells in both types of BLT mice (Figures 3B and 3C). In contrast, the numbers of hCD19+ B
cells were significantly higher in N/S-BLT versus NSG-BLT mice (Figures 3B and 3C).
We next used IFA to characterize the human immune cells in the intestinal lamina propria of
BLT mice. In comparison to the relative abundance of human B cells present in the GALT
structures of N/S-BLT mice, hCD19+ B cells were infrequent in the lamina propria of both
N/S-BLT and NSG-BLT mice (Figure 3D). In contrast, hCD3+ T cells, hCD11c+ dendritic
cells and hCD68+ macrophages were identified here in both types of BLT mice (Figures
3D). The restricted distribution of human B cells in the human GALT structures of N/S-BLT
mice was confirmed using a second pan B cell marker, hCD20 (Figures S2A).
The pan B cell surface markers (CD19 and CD20) are appropriate to study the distribution
of human B cell at most stages of differentiation; however, the reduction or disappearance of
these markers on fully differentiated B cells precludes their utilization to determine the
presence of plasma cells (Benckert et al., 2011; Farstad et al., 2000). Therefore, other B cell
differentiation markers were used to investigate the intestinal plasma cells in N/S-BLT mice.
In the GALT structures, we found cells expressing human activation-induced cytidine
deaminase (AID) (Figure S2A). This observation is consistent with the presence of class-
switched hIgA+ and hIgG+ cells (Figure S2A). In addition, hIgM+ cells were also found in
these structures (Figure S2A). The anti-hIgM antibody (Taylor and Burns, 1974) used for
this IFA is strongly reactive with plasma cells producing hIgM, but not with mature naïve B
cells bearing surface hIgM, defining the hIgM+ cells found in the GALT structures as
unswitched hIgM-producing plasma cells.
To investigate the maturation of B cells to hIgA-producing plasma cells, we performed
additional IFA. We found that all hIgA+ cells were consistently negative for hCD20
expression, whereas some hIgA+ cells expressed HLA-DR, another mature naïve B cell
marker (Farstad et al., 2000) (Figure S2B). hCD27, hCD38 or hCD138 were also expressed
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on some hIgA+ cells confirming their status as fully differentiated plasma cells (Figure S2B)
(Farstad et al., 2000). These results indicate that the human GALT structures contain
heterogeneous hIgA+ cell populations at multiple differentiation stages. Quantitative IFA
revealed that the SI lamina propria of N/S-BLT mice harbors more hCD45+hIgA+ cells
versus hCD45+hIgM+ cells or hCD45+hIgG+ cells (Figures 4A and 4B). In contrast, very
few hCD45+ cells expressing hIgA, hIgM or hIgG were found in NSG-BLT mice (Figures
4A and 4B). These results confirmed our hypothesis that the presence of human immune cell
lineages in the intestinal lamina propria of BLT mice is dependent on the presence of human
GALT structures. Furthermore, the fact that N/S-BLT mice have cryptopatches (Figures 2)
together with the fact that intraepithelial T cell numbers are significantly higher in N/S-BLT
mice relative to NSG-BLT mice (Denton et al., 2012) suggests that intraepithelial
lymphocyte reconstitution is partially cryptopatch/GALT dependent.
Despite the absence of GALT structures in NSG-BLT mice, their lamina propria contained a
small number of hCD45+hIg+ cells (Figures 4A and 4B). We hypothesized that the presence
of human cells in the gut-draining mesenteric lymph nodes (MLN) could explain this
observation. Our hypothesis was based on the following key facts: (i) both GALT and MLN
are sites where human IgA+ cells, in addition to T cells, are programmed to migrate into the
intestinal lamina propria (Mora and von Andrian, 2009); (ii) a functional IL-7R is
dispensable for the development of MLN anlagen (Cao et al., 1995); and (iii) cryptopatch
formation is completely dependent on IL-7R-signaling (Kanamori et al., 1996). We found
the MLN in both N/S-BLT and NSG-BLT mice are similarly reconstituted with hCD3+ T
cells, hCD19+ B cells, hCD11c+ dendritic cells and hCD68+ macrophages (Figure S3). We
also found class-switched hIgA+ and hIgG+ cells and unswitched hIgM+ cells in the MLNs
of both types of BLT mice (Figure S3). These results are consistent with our hypothesis
that hIg+ cells in the lamina propria of NSG-BLT mice could originate from the MLN.
IgA1- and IgA2-secreting plasma cells in the lamina propria of N/S-BLT mice
A hallmark of the human GI tract immune system is the secretion of IgA in the intestinal
lamina propria (McGhee et al., 2007; Pabst, 2012). We used ELISPOT analyses to quantitate
the antibody-secreting plasma cells in the SI of N/S-BLT and NSG-BLT mice. N/S-BLT
mice harbored more hIgA-secreting plasma cells than hIgG-secreting plasma cells (Figures
5A and 5B). In contrast, NSG-BLT mice had few plasma cells secreting hIg in general and
fewer plasma cells secreting hIgA and hIgG versus N/S-BLT mice (Figures 5A and 5B).
Consistent with human data (Farstad et al., 2000), we found that hIgA+ cells in the SI lamina
propria of N/S-BLT mice exhibited a surface expression profile indicative of fully
differentiated human plasma cells (i.e., hCD20negHLA-DRneghCD27+hCD38+hCD138+)
(Figure 5C). In humans there are two IgA subclasses: hIgA1 and hIgA2 (Mestecky et al.,
1999). Like in humans, both are present in the GALT structures and the intestinal lamina
propria of N/S-BLT mice (Figures 5D and S4). Together, these results emphasize
similarities between the N/S-BLT and the human GI tract immune systems indicating that N/
S-BLT mice are suitable for the study of GALT pathologies.
GALT destruction in N/S-BLT mice after HIV infection
HIV infection results in a catastrophic loss of CD4+ T cells in the GI tract that is not fully
reflected in the periphery (Brenchley and Douek, 2008). Analysis of the human T cells in the
GALT structures of N/S-BLT mice showed that, like in healthy humans (Mehandru et al.,
2004), there is a preponderance of CD4+ T cells. Specifically, the CD4/CD8 T cell ratio in
the GALT structures of N/S-BLT mice was 1.84 (+/− 0.19 SD), well within the range
(1.6-3.1) reported for healthy human GALT (Mehandru et al., 2004). After rectal exposure,
HIVgagp24-expressing cells are present in the GALT structures of N/S-BLT mice (Figure
S5A). Our results show a 7.6-fold reduction in the numbers of hCD4+ T cells in the GALT
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structures of these mice due to HIV infection (Figure S5B) which is consistent with our
previous flow cytometry-based observation that HIV infection decreased hCD4+ T cells in
the intestinal lamina propria and intraepithelial compartments (Denton et al., 2008; Sun et
al., 2007). In contrast, there was no observed difference in hCD8+ T cell levels in HIVneg
versus HIV+ animals (Figure S5C). Consistent with HIV patient data (Mehandru et al.,
2007),hperforin+ cells were significantly increased in the GALT structures of HIV+ N/S-
BLT mice (Figure S5D). These findings highlight the accurate manner in which N/S-BLT
mice recapitulate CD4+ T cell depletion in the GALT structures.
Overall, these results support the following model for the development of human GALT
structures in N/S-BLT mice. First, endogenous cryptopatches are populated with mouse LTi
cells that provide an appropriate local microenvironment for the recruitment of human
hematopoietic cells. Then recruited human CD4+ T cells, CD8+ T cells, B cells, dendritic
cells and macrophages develop human GALT structures. Human B cells in these structures
express AID and differentiate into IgA-producing plasma cells that migrate to the intestinal
lamina propria. Once established, these GALT structures are susceptible to HIV-induced
depletion of hCD4+ T cells, further demonstrating how human GALT structures in N/S-BLT
mice recapitulate key phenotypes of human GALT during health and disease.
DISCUSSION
The human GI tract immune system is critically important in the defense against intestinal
pathogens and the maintenance of immune tolerance to commensal microorganisms (Hooper
and Macpherson, 2010; McGhee et al., 2007; Pabst, 2012). These activities represent a
delicate balance that is susceptible to disruption in patients with GALT-damaging infectious
or autoimmune diseases (Brenchley and Douek, 2008; Khor et al., 2011). In vivo studies of
GALT genesis, biology and pathology have significant difficulties that are intrinsic to
human studies. Reproducing human GALT biology using ex vivo organ cultures has proven
to be challenging (Hicks et al., 1996). If available, an in vivo xenograft model that
recapitulates human GALT development and pathologies could offer the following
advantages to GALT research: (i) much longer experimental window (>6 months) (Denton
et al., 2008) relative to ex vivo approaches (~48 h) (Hicks et al., 1996); (ii) much larger
tissue sample (entire intestine with GALT) relative to ex vivo samples (2-3 mm2 biopsy
specimens) (Hicks et al., 1996); (iii) mechanisms contributing to human GALT genesis can
be studied; (iv) permits inter-organ cell migration patterns to and from GALT; (v)
physiological methods to induce GALT pathogenesis [e.g., mucosal HIV transmission (Sun
et al., 2007)]; (vi) multiple organs can be harvested simultaneously facilitating comparative
analyses with GALT; and (vii) human GALT cells exposed to human pathogens in vivo can
be targeted by human therapeutics. To gain these experimental advantages in GALT
research, we bioengineered an appropriate xenotransplantation model.
In mice, cryptopatches serve as anlagen for the postnatal formation of ILFs (Eberl, 2005;
Eberl and Littman, 2004; van de Pavert and Mebius, 2010). This information, coupled with
the recent description of cryptopatch-like structures in human intestines (Lugering et al.,
2010), led us to hypothesize that mouse cryptopatches may serve as anlagen for human
GALT genesis. To test this hypothesis, we needed strains of immunodeficient mice with or
without cryptopatches in their GI tract and a humanization strategy that would result in the
in situ development and systemic dissemination, including throughout the GI tract, of human
hematopoietic cells. We identified two closely related immunodeficient mouse strains (N/S
and NSG) that differ genetically only at the IL-2Rγ chain locus, leading to a differential
phenotype in their ability to develop cryptopatches. Of the multiple strategies described for
the humanization of immunodeficient mouse strains (Denton and Garcia, 2011; Shultz et al.,
2012; Shultz et al., 2007), BLT humanization was chosen because it results in: development
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of human T cells in N/S mice (Melkus et al., 2006) and reproducible human reconstitution of
mouse intestines (Denton et al., 2012). This information combined with the lack of detailed
information regarding human GALT structure development in BLT mice led us to utilize the
BLT humanization strategy coupled with the utilization of the N/S and NSG mouse strains
to test our hypothesis that mouse cryptopatches may also serve as anlagen for human GALT
genesis.
Confirming our hypothesis, a major finding of these studies is the demonstration that
endogenous cryptopatches in the SI of N/S mice serve as anlagen for the development of
human GALT structures following BLT humanization (Figures 2). These GALT structures
contain human T cells, B cells, dendritic cells and macrophages (Figures 3), indicating that
homing molecules produced by mouse LTo cells in cryptopatches cross-react sufficiently
with their corresponding receptors on human hematopoietic cells to induce GALT
formation. The critical role for cryptopatches in human GALT development is highlighted
by the fact that cryptopatch-lacking NSG-BLT mice do not develop human GALT structures
(Figures 2). The abundance of human T cells, B cells, dendritic cells and macrophages in all
peripheral tissues of NSG-BLT mice (Denton et al., 2012) does not rescue the GALT-
deficient phenotype in these animals. These observations represent a fundamental
breakthrough in our mechanistic understanding of the role of cryptopatches in human GALT
genesis.
A second major finding is that human B cells in the GALT structures of N/S-BLT mice
recapitulate essential roles of B cells present in human GALT (He et al., 2007; Spencer et
al., 2012). As in human intestines (He et al., 2007; Mestecky et al., 1999; Spencer et al.,
2012), in N/S-BLT mice hIgA1+ and hIgA2+ cells are present in both the GALT structures
and the lamina propria (Figure 5). A difference we noted was a slightly inverted ratio
of hIgA1+ and hIgA2+ cells relative to human data (Figure S4) (He et al., 2007; Mestecky et
al., 1999; Spencer et al., 2012). This could be due to either the chimeric intestinal
environment and/or the differential commensal microbiota between humans and mice
(Denton and Garcia, 2011; Shultz et al., 2012; Shultz et al., 2007; Turnbaugh et al., 2009).
Overall, our findings highlight the many similarities between GALT structures of N/S-BLT
mice and human GALT.
In conclusion, here we modeled human GALT development and pathogenesis in vivo using
a human-mouse chimeric model. Key mechanistic discoveries include the demonstration that
mouse cryptopatches can initiate human GALT genesis, demonstration that human intestinal
IgA production is initiated in the GALT structures and the depletion of human CD4+ T cells
in the GALT structures as a result of HIV infection. Our findings have significant potential
to stimulate further research on GALT damage or malfunction as observed in HIV disease
and IBDs. The histology-based analyses of the GALT structures present in HIV-infected N/
S-BLT mice presented here exemplify possible analyses in this model which is the most
comprehensive experimental platform currently available for the study and the pre-clinical
efficacy testing of therapeutics designed to repair disease-damaged GALT.
EXPERIMENTAL PROCEDURES
Comprehensive Experimental Procedures in Supplemental Material Online Human-mouse
chimeric model
NOD/SCID (NOD.CB17-Prkdcscid/J, alias N/S), N/SIL-2Rγnull (NOD.Cg-
PrkdcscidIl2rγtm1Wjl/Szj, alias NSG) and BALB/c mice were obtained from The Jackson
Laboratory (Bar Harbor, ME). All mice were maintained either at the Division of Laboratory
Animal Medicine at the University of North Carolina at Chapel Hill or the Animal
Resources Center at the University of Texas Southwestern Medical Center at Dallas in
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accordance with protocols approved by each institution’s Institutional Animal Care and Use
Committee. N/S-BLT (n=13) or NSG-BLT mice (n=13) mice were prepared essentially as
previously described (Denton et al., 2012; Melkus et al., 2006). Tissue for implantation was
obtained from Advanced Bioscience Resources, (Alameda, CA). Human reconstitution in
the peripheral blood of BLT mice was monitored by polychromatic flow cytometry with the
directly conjugated antibodies described in Table S1.
Histological and cellular analyses
SI, LI, MLNs, spleens, livers and lungs were harvested, fixed with 4 % paraformaldehyde
(Sigma, St Louis, MO) and embedded in either paraffin (Leica, Newcastle Upon Tyne,
United Kingdom) or OCT compound (Sakura, Torrance, CA). Tissue sections (5 μm) were
analyzed as detailed in supplemental materials. Antibodies utilized for histological analyses
are described in Tables S2 and S3. SI of BLT mice and control BALB/c mice were
processed to isolate lamina propria mononuclear cells essentially as previously described
(Sun et al., 2007). Cells were utilized for ELISPOT as detailed in supplemental materials.
All statistical analyses (alpha level: 0.05) were performed in Prism version 5 (Graph Pad, La
Jolla, CA).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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· Cryptopatches function as a required scaffold/foundation wherein human GALT
develops.
· Plasma cells differentiated in human GALT migrate to the intestinal lamina propria.
· Human GALT generates human plasma cells producing either human IgA1 or IgA2.
· HIV infection leads to massive CD4+ T cell loss within human GALT.
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Figure 1. Hematopoietic cells and structures within the small intestine of N/S, NSG and BALB/c
mice
H&E (A) and IFA (B) images of SI from N/S (top), NSG (center) and BALB/c (bottom)
mice are shown. Corner images in (A): high magnification of the cryptopatches in N/S and
BALB/c mice. N/S mouse cryptopatches can become enlarged with defined follicle-
associated epithelium giving rise to structures that are morphologically similar to BALB/c
mouse GALT (i.e., ILFs and PPs). (B) IFA revealed the expected absence of mouse T and B
cells in the cryptopatches found in N/S mice. Corner images: higher magnification minus
DAPI. Scale bars =100 μm. (C-D) Flow cytometry analyses of the intestinal lamina propria
from N/S and NSG mice confirmed the absence of mCD3+ T cells and mCD19+ B cells in
these immunodeficient mouse strains and their presence in BALB/c mice. Representative
flow plots (C) and cumulative data (D) (n=3 per strain). All cell isolations were performed
under the same conditions and equal numbers of events were collected per sample. (E-
F) mCD45+mLinnegmIL-7Rα+mc-kit innate lymphoid cells are present in the SI lamina
propria of both N/S and BALB/c mice, but not NSG mice. (E) Innate lymphoid cells in the
SI lamina propria were identified via flow cytometry (n=3, each strain). Far left panels:
isotype controls lineage cocktail. Pairs of middle panels: mCD45+mLinneg cells examined
for mIL-7Rα and mc-kit expression. Far right panels: isotype control for mIL-7Rα and mc-
kit. Representative plots from 1 mouse of 3 analyzed per strain. (F) Quantification of the
absolute numbers of innate lymphoid cells. Student’s t-test was used to confirm the
statistical significance of the difference in the number of mLinnegmIL-7Rα+mc-kit+ cells
present in N/S, NSG and BALB/c mice (n=3 per strain). See also Figure S1.
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Figure 2. Endogenous cryptopatches, devoid of mouse lymphocytes, mature into expanded
immune aggregates in the SI of N/S mice following BLT humanization
(A) Representative low magnification images of H&E-stained lower SI (ileum, ~6 cm long
when embedded) of non-humanized and BLT-humanized N/S and NSG mice. Cryptopatches
(blue arrowheads) are present in the SI of both non-humanized and BLT-humanized N/S
mice. In addition, expanded immune aggregates (red arrows) are observed in N/S-BLT mice.
High magnification images illustrate a representative enlarged cryptopatch and an expanded
immune aggregate in N/S-BLT mice. Also shown are intestinal villi from NSG-BLT mice.
Scale bar=250 μm. (B) IFA show that the enlarged cryptopatches in non-humanized N/S
mice harbor only mCD45+ cells (green, left panel) (top row), while in N/S-BLT mice there is
an accumulation of hCD45+ cells (red, center panel) alongside the mCD45+ cells (middle
row). The relative proportion of hCD45+ cells to mCD45+ cells shifts dramatically as
cryptopatches expand to become immune aggregates (bottom row). Merged plus DAPI
(right). Scale bar=50 μm. See also Figure S1.
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Figure 3. The distribution of hCD19
+ B cells in the SI of N/S-BLT mice is restricted to GALT
structures
(A) Expanded immune aggregates of N/S-BLT mice were defined as human GALT
structures by the presence of hCD3+ T cells, hCD19+ B cells, hCD11c+ dendritic cells
and hCD68+ macrophages. (B and C) Flow cytometry analyses show equivalent numbers
of hCD3+ T cells in the SI of N/S-BLT (n=4) and NSG-BLT (n=4) mice. In contrast, the
absolute number of hCD19+ B cells in the SI of N/S-BLT mice is higher versus NSG-BLT
mice (Student’s t-test; N.S.=not significant). Gating: lymphoid→hCD45 positive →hCD3
or hCD19+. (D) The lack of human GALT structures in NSG-BLT mice limits direct
comparison to the intestinal villi of the 2 types of BLT mice. Scale bars=50 μm.
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Figure 4. Small intestinal lamina propria of N/S-BLT mice exhibits a large number of human
immunoglobulin-producing cells
(A) SI of both N/S-BLT (n=4) and NSG-BLT (n=4) mice were stained with anti-hIgM, hIgG
or hIgA (green, left column) and anti-hCD45 (red, center column). The merged images with
a DAPI-counterstained image are shown on the right panel. Higher magnification images are
presented under the original low magnification images. Scale bar=50 μm. (B) Images
similar to those in (A) from 4 mice per group were digitally converted using Definiens
Tissue Studio® to quantitate the numbers of hCD45+ cells expressing either hIgM or hIgG
or hIgA. (Student’s t-test; lines connect compared data sets). See also Figures S2 and S3.
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Figure 5. hIgA-secreting cells are the most common plasma cells found in the SI of N/S-BLT
mice
(A-B) Mononuclear cells isolated from the SI of N/S-BLT (n=4) and NSG-BLT (n=4) mice
were used for ELISPOT analyses to quantitate antibody-secreting plasma cells (ASCs).
Images from a representative mouse per group (A). Cells secreting each Ig from each type of
BLT mouse were compared by Student’s t-test (lines connect compared data sets) (B). (C)
Fully differentiated hIgA+ plasma cells in the SI lamina propria of N/S-BLT mice
express hCD138, hCD27 and hCD38 but not hCD20 or HLA-DR. Images are hIgA (green,
left), hCD138, hCD20, hCD27, hCD38 or HLA-DR (red, center) and merged plus DAPI
(right). (D) hIgA1- and hIgA2-producing plasma cells are found in both the human GALT-
structures and the lamina propria of N/S-BLT mice. Images include: polyclonal anti-hIgA
with binding specificities for both hIgA1 and hIgA2 (green, left), monoclonal antibodies
specific for either hIgA1 or hIgA2 (red, center) and the merged plus DAPI (right). Scale
bars=50 μm. See also Figure S4.
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